Denali Therapeutics Announces First Patient Dosed in Phase 1B Study of DNL201 for Parkinson’s Disease

by bizlift | Dec 10, 2018 | Denali Press Releases, Portfolio News

AiCure’s Revenue Soars as it Bolsters Client List and Executive Team

by bizlift | Dec 3, 2018 | AiCure Press Releases, Portfolio News

New AAN Collaboration with Verana Health

by bizlift | Dec 1, 2018 | Portfolio News, Verana Health Press Releases

COMPASS THERAPEUTICS ANNOUNCES PRECLINICAL DATA ON LEAD ANTIBODY PROGRAM AND NK CELL ENGAGER PLATFORM TO BE PRESENTED AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER ANNUAL MEETING

by bizlift | Nov 6, 2018 | Compass Press Releases, Portfolio News

BlackThorn Therapeutics Names Bill Martin, Ph.D., President and Chief Operating Officer

by bizlift | Nov 5, 2018 | BlackThorn Press Releases, Portfolio News

Twist Bioscience Corporation Announces Pricing of Initial Public Offering

by bizlift | Oct 31, 2018 | Portfolio News, Twist Press Releases